Clinical Trials Browser

Phase 1/2 × Withdrawn × Pemetrexed × Clear all

NCT04430933 2021-08-18

A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT00668499 2014-05-21

A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

Phase 1/2 Withdrawn

Other solid neoplasmThoracic

Mesothelioma

NCT01353482 2012-03-22

MESO-02

Phase 1/2 Withdrawn

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma